vimarsana.com

Latest Breaking News On - Department of clinical pharmacology bernd jilma - Page 1 : vimarsana.com

New antibody therapy shows promise in combating kidney transplant rejection

Antibody-mediated rejection (AMR) is one of the most common causes of kidney transplant failure. To date, however, no treatment has proven effective in combating this complication in the long term.

Austria
Vienna
Wien
Berlin
Germany
Canada
Katharina-mayer
Klemens-budde
Department-of-clinical-pharmacology-bernd-jilma
University-of-vienna
Department-of-medicine
Clinical-division-of-nephrology

New therapy proven effective against rejection in kidney transplantation

Antibody-mediated rejection (AMR) is one of the most common causes of kidney transplant failure. To date, however, no treatment has proven effective in combating this complication in the long term.

Canada
Austria
Vienna
Wien
Berlin
Germany
Katharinaa-mayer
Katharina-mayer
Klemens-budde
Department-of-medicine
Clinical-division-of-nephrology
Department-of-clinical-pharmacology-bernd-jilma

vimarsana © 2020. All Rights Reserved.